ROVI — Laboratorios Farmaceuticos Rovi Share News
0.000.00%
Last trade - 00:00- €2.95bn
- €2.94bn
- €743.48m
Brief: Rovi To Propose Dividend Of 0.9594 Eur/Shr
Brief: ROVI FY Revenue EUR 743.5 Million Vs. IBES Estimate EUR 732.8 Million
Brief: Rovi FY EBITDA 216.2 Mln Euros
Brief: Rovi FY Net Profit At 140.4 Mln Euros
BNP sees slowdown in Spanish mid-caps in 2026 after outperforming year
Brief: Rovi And Roche Sign Final Agreement For Manufacture Of New Medicine
Spanish stocks - Factors to watch on Nov 6
Brief: Rovi Sees 2026 Operating Revenue To Increase By Up To Low Double-Digit Percentage Vs 2025
Brief: ROVI 9M Revenue EUR 525.1 Million
Rovi jumps after announcing drug deal with Roche
Brief: Rovi To Collaborate With Roche On New Drug Manufacturing
Spanish stocks - Factors to watch on Sept 30
Brief: Rovi's Subsidiary Buys Injectable Drug Product Manufacturing Site In Phoenix, Arizona
Europe Research Roundup: Euronext, Genuit Group, Melrose Industries
Rovi rises after EBITDA beats consensus
Spanish stocks - Factors to watch on July 24
Brief: Rovi Sees 2025 Operating Revenue To Decrease By A Mid-Single-Digit Percentage Versus 2024
Brief: Rovi H1 Net Profit At 39.7 Mln Euros
Brief: ROVI H1 Revenue EUR 314.6 Million